Immune senescence in precision longevity medicine
ABOPM's precision longevity medicine principles span six domains including immune senescence; Intervene Immune ranks #5 in the Eternal Search company ratings at 35.4 points.
Immune senescence is one of six domains in the precision longevity medicine framework from the American Board of Precision Medicine (ABOPM). The other five: cardiovascular aging, neurocognitive decline, metabolic disease, musculoskeletal deterioration, and hormonal aging. The approach across all six is molecularly grounded.
Intervene Immune holds the #5 spot in the Eternal Search company ratings (35.4 points).
Open the related Eternal Search page
Sources
Top 10 Longevity & Anti-Aging Breakthroughs of 2025 - Healthspan
Longevity Medicine | American Board of Precision Medicine
The ABOPM's formal classification of immune senescence as a peer-level clinical domain alongside cardiovascular and neurocognitive aging signals institutional recognition of a specific biological mechanism most people experience but cannot name. Connecting this to Intervene Immune's #5 company ranking and the Eternal Search glossary page gives readers a named mechanism, a commercial example, and a place to dig deeper.